Evercore ISI initiated coverage on Waystar Holding Corp. with a new price target
$WAY
EDP Services
Technology
Evercore ISI initiated coverage of Waystar Holding Corp. with a rating of Outperform and set a new price target of $25.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/14/2025 | $45.00 | Buy | Truist |
| 2/11/2025 | $51.00 | Buy | Jefferies |
| 11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
| 7/2/2024 | $27.00 | Buy | BofA Securities |
| 7/2/2024 | $24.00 | Overweight | Barclays |
| 7/2/2024 | $27.00 | Buy | Deutsche Bank |
| 7/2/2024 | $32.00 | Buy | Goldman |
| 7/2/2024 | $24.00 | Overweight | JP Morgan |
LEHI, Utah and LOUISVILLE, Ky., May 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY) ("Waystar"), a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 12,500,000 shares of its common stock being offered by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock. Waystar is not selling any shares and will not receive any proceeds from the sale
Recognition underscores the differentiated value of Waystar's software platform in addressing nearly half a trillion dollars in administrative waste LEHI, Utah and LOUISVILLE, Ky., May 8, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced MedTech Breakthrough named it Best Overall Healthcare Payments Solutions Provider. This marks the fourth consecutive year that MedTech Breakthrough recognized Waystar, previously awarding the company the Healthcare Payments Innovation Award and Best New Technology Solution for Healthcare Payments.
LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins and Chief Financial Officer Steve Oreskovich will speak at two upcoming investor conferences. Oreskovich will present at the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025, at 8:40 a.m. PT. Hawkins will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at 12 p.m. CT. Both presentations will stream live on Waystar's In
Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
S-1 - Waystar Holding Corp. (0001990354) (Filer)
DEFA14A - Waystar Holding Corp. (0001990354) (Filer)
8-K - Waystar Holding Corp. (0001990354) (Filer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Q1 revenue growth of 14% year-over-year Q1 net income of $29.3 million and non-GAAP net income of $58.7 million Q1 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the first quarter ended March 31, 2025. "Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins excee
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U